The HFD group demonstrated an increase in body weight, the development of hepatic steatosis, hepatocyte ballooning, increased fasting serum glucose levels, and decreased adiponectin levels, suggesting hyperglycemia and insulin resistance [22]. Here, ADIPOQ is linked to Hepatic steatosis.